Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-02-07 to 2023-02-08
Current total value of award: $7109.52
Description: 4559857494!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML